Interventions for preventing oral mucositis for patients with cancer receiving treatment
Interventions for preventing oral mucositis for patients with cancer receiving treatment
Cochrane Review
10 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Failure of therapy
nonâselective carious tissue removal and CR |
5.0 | - | - | Not assessed |
|
Failure of therapy: SE vs HT â primary, cavitated but not deep
HT |
8.94 | - | - | Not assessed |
|
Failure of therapy: SE vs HT â primary, deep
HT |
1.95 | - | - | Not assessed |
|
Failure of therapy: CR vs SW â primary, deep
SW |
2.43 | - | - | Not assessed |
|
Failure of therapy: CR vs SW â permanent, deep
SW |
2.06 | - | - | Not assessed |
|
Failure of therapy: CR vs SE â permanent, deep
SE |
11.32 | - | - | Not assessed |
|
Failure of therapy: CR vs SE â primary, deep
SE |
4.43 | - | - | Not assessed |
|
Failure of therapy: CR vs SE â primary, cavitated but not deep
SE |
0.62 | - | - | Not assessed |
|
Failure of therapy: SW vs SE â primary, deep
SW |
2.05 | - | - | Not assessed |
|
Failure of therapy: SW vs SE â permanent, deep
SW |
2.25 | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD013039 |
| Outcomes: | 10 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
10